Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Annexon Inc is a biotechnology business based in the US. Annexon Inc shares (ANNX) are listed on the NASDAQ and all prices are listed in US Dollars. Annexon Inc employs 75 staff and has a market cap (total outstanding shares value) of 0.00.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Active traders
| Latest market close | $6.28 |
|---|---|
| 52-week range | $2.06 - $22.34 |
| 50-day moving average | $5.67 |
| 200-day moving average | $5.33 |
| Wall St. target price | $18.71 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-3.64 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $6.28 from 2022-10-03
| 1 week (2022-09-27) | 2.45% |
|---|---|
| 1 month (2022-08-31) | N/A |
| 3 months (2022-07-01) | 61.44% |
| 6 months (2022-03-31) | N/A |
| 1 year (2021-10-04) | -66.74% |
|---|---|
| 2 years (2020-10-02) | -76.71% |
| 3 years (2019-09-30) | N/A |
| 5 years (2017-09-30) | N/A |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -33.03% |
| Return on equity TTM | -62.79% |
| Profit margin | 0% |
| Book value | $4.35 |
| Market capitalisation | $294.3 million |
TTM: trailing 12 months
We're not expecting Annexon Inc to pay a dividend over the next 12 months.
Over the last 12 months, Annexon Inc's shares have ranged in value from as little as $2.06 up to $22.335. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Annexon Inc's is 0.4784. This would suggest that Annexon Inc's shares are less volatile than average (for this exchange).
Annexon, Inc. , a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, a monoclonal antibody, which is in Phase II/III clinical trials to treat patients with guillain- barré syndrome; Phase II trial in patients with warm autoimmune hemolytic anemia; and Phase II clinical trial for Huntington's disease and amyotrophic lateral sclerosis. The company is also developing ANX009 that is in Phase Ib trial in patients with lupus nephritis; and ANX007, which is in Phase II clinical trials to treat patients with geographic atrophy. In addition, it develops ANX105, an investigational monoclonal antibody targeting neurodegenerative indications; and ANX1502, an investigational oral small molecule for the treatment of certain autoimmune indications. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
Our list of 10 dividend stocks to watch in 2022.
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.